Showing results (501-510 of 530) with videos related to

Sort By:
Pageof 53
American Heart Journal|April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisMatthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Plos One|August 15, 2019
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Arthritis and Rheumatism|May 28, 2010
Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritisAltan Ercan, Jing Cui, Dereck E W Chatterton, et al.
Plos One|April 20, 2019
Prevalence and predictors for sustained remission in rheumatoid arthritisYoon-Kyoung Sung, Kazuki Yoshida, Femke H M Prince, et al.
Journal of Autoimmunity|August 3, 2024
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologiesEmily G Oakes, Eilish Dillon, Katherine A Buhler, et al.
Contemporary Clinical Trials|September 13, 2012
The MeTeOR trial (Meniscal Tear in Osteoarthritis Research): rationale and design featuresJeffrey N Katz, Christine E Chaisson, Brian Cole, et al.
American Heart Journal|September 24, 2016
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trialNiteesh K Choudhry, Thomas Isaac, Julie C Lauffenburger, et al.
European Heart Journal|October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialFrank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine|December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for ArthritisSteven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
Pharmacoepidemiology and Drug Safety|September 16, 2011
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systemsLisa J Herrinton, Jeffrey R Curtis, Lang Chen, et al.
Pageof 53